MannKind develops dry powder inhaler for pulmonary hypertension treatment

Go back to MannKind develops dry powder inhaler for pulmonary hypertension treatment
Mannkind Corporation (NASDAQ: MNKD) Delayed: 3.29 -0.13 (3.8%)
Previous Close $3.42    52 Week High $2.51 
Open $3.40    52 Week Low $0.41 
Day High $3.41    P/E N/A 
Day Low $3.23    EPS $-0.64 
Volume 4,549,652       

United Therapeutics Corp (NASDAQ: UTHR) Delayed: 549.16 +16.38 (3.07%)
Previous Close $532.78    52 Week High $164.04 
Open $528.92    52 Week Low $97.52 
Day High $551.15    P/E 100.39 
Day Low $528.92    EPS $5.47 
Volume 577,863